Regulations for the Administration of Overseas Inspection of Pharmaceuticals & Medical Devices

The National Medical Products Administration (NMPA) of China issued the “Provisions on the Administration of Overseas Inspection of Drugs and Medical Devices” on 26 December 2018.  The intent of the document is to regulate overseas inspection of drugs and medical devices to ensure the quality of the products being sold within the territory of the People’s Republic of China.  The requirements became effective on the date of release.

Click Here to View Official Publication

Download Resource